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In Brief
Bowman et al. show that substance P
(SP), acting through the NK1 receptor,
increases recycling of mu-opioid
receptors (MORs) after fentanyl, but not
morphine. This increase requires PKC-
mediated phosphorylation of MOR.
Furthermore, SP increases neuronal
sensitivity to opioids and reduces acute
tolerance to fentanyl, but not morphine.
This suggests a mechanism for crosstalk
between inflammatory pain and opioid
analgesia.
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How neurons coordinate and reprogram multiple
neurotransmitter signals is an area of broad interest.
Here, we show that substance P (SP), a neuropep-
tide associated with inflammatory pain, reprograms
opioid receptor recycling and signaling. SP, through
activation of the neurokinin 1 (NK1R) receptor, in-
creases the post-endocytic recycling of the mu-
opioid receptor (MOR) in trigeminal ganglion (TG)
neurons in an agonist-selective manner. SP-medi-
ated protein kinase C (PKC) activation is both re-
quired and sufficient for increasing recycling of exog-
enous and endogenous MOR in TG neurons. The
target of this cross-regulation is MOR itself, given
that mutation of either of two PKC phosphorylation
sites on MOR abolishes the SP-induced increase
in recycling and resensitization. Furthermore, SP
enhances the resensitization of fentanyl-induced,
but not morphine-induced, antinociception in mice.
Our results define a physiological pathway that
cross-regulates opioid receptor recycling via direct
modification of MOR and suggest a mode of homeo-
static interaction between the pain and analgesic
systems.
INTRODUCTION
Most neurotransmitter signals are transduced by G protein-
coupled receptors (GPCRs), the largest family of signaling re-
ceptors (Pierce et al., 2002; Rosenbaum et al., 2009; Premont
and Gainetdinov, 2007; Shepherd and Huganir, 2007; von Zas-
trow and Williams, 2012). The strength of a neuronal response
directly depends on surface receptor numbers. Therefore, regu-
lation of this number via membrane trafficking is critical for
modulating neuronal responsiveness to a given signal (Anggono
and Huganir, 2012; Gainetdinov et al., 2004; Marchese et al.,
2008; Yudowski et al., 2009). It is accepted that membrane traf-
ficking can control the number of surface receptors and there-Cellfore signaling, and many mechanisms have been identified.
Emerging evidence suggests that signaling also can control
membrane trafficking, but the mechanisms that underlie such
crosstalk are still largely unresolved (Jean-Alphonse and Hanya-
loglu, 2011).
Post-endocytic receptor sorting, a trafficking step critical for
receptor physiology (Sorkin and von Zastrow, 2009; Anggono
and Huganir, 2012; Marchese et al., 2008; Scita and Di Fiore,
2010; Williams et al., 2013), provides a potential point for such
crosstalk. Activated surface receptors are rapidly internalized
by clathrin-mediated endocytosis and transported to the en-
dosome, causing receptor removal from the cell surface,
which is associated with a loss of cellular sensitivity (Alvarez
et al., 2002; Claing et al., 2002; Hanyaloglu and von Zastrow,
2007; Keith et al., 1996; Martini and Whistler, 2007). Cellular
sensitivity to further extracellular signals is then determined
by post-endocytic receptor sorting between the degradative
and recycling pathways, as small changes in recycling rates
can cause relatively large changes in surface receptor num-
bers over physiological timescales (Sorkin and von Zastrow,
2009; Arttamangkul et al., 2012; Jean-Alphonse and Hanyalo-
glu, 2011; von Zastrow and Williams, 2012). How receptor re-
cycling is controlled by heterologous signaling pathways in a
physiological context is a fundamental question that is still
not very well understood (Marchese et al., 2008; Williams
et al., 2013).
Here we focused on two signaling pathways that function-
ally interact—pain and analgesia—as physiologically relevant
examples for potential signaling crosstalk. Pain in nociceptive
neurons is associated with activation of the neurokinin 1 re-
ceptor (NK1R) by substance P (SP) (Perl, 2007; De Felipe
et al., 1998), while analgesia is primarily mediated by opioids
via the mu-opioid receptor (MOR) (Chen and Marvizo´n, 2009;
Kieffer, 1995; Lao et al., 2008). We show that NK1R activation
by SP increases MOR post-endocytic recycling in sensory
neurons, via a cross-regulatory mechanism based on direct
modification of MOR. NK1R signaling also increases the
resensitization of MOR-mediated antinociception in mice.
Our results provide a physiologically relevant example for
crosstalk between signaling pathways at the level of receptor
trafficking.Reports 10, 1925–1936, March 24, 2015 ª2015 The Authors 1925
Figure 1. SP Increases Post-endocytic Recycling of MOR
(A) Schematic of the quantitative ratiometric recycling assay in TG neurons.
(B) Example images of FLAG-MOR in primary TG neurons: surface control (surf ctrl), internalization control (intern), DG washout (rec), and washout with SP (rec +
SP). Primary anti-FLAG labeling showing the total pool of receptors initially on the surface (total 488) is green in the overlay. Secondary antibody labeling showing
the fraction of the initial pool on the surface at the end of the treatment (surf 568) is red in the overlay. A ratio of the 568 to 488 fluorescence gives the fraction of the
initial pool present on the surface at the end. Scale bar represents 10 mm.
(C) Percentage recycling calculated from the ratios of surface (568) to total (488) in each condition (mean ±SEM; n = 77 surf ctrl, 78 intern, 69 rec, and 68 rec + SP).
(D) Cytofluorograms showing pixel-level fluorescence correlation between total and surface-only pools. The surf ctrl shows strong correlation between the two
channels; the intensity values trend to a single diagonal line. DG (intern) causes separation of the points into two populations, consistent with a decrease in
colocalization because the anti-FLAG on internalized MOR is not accessible to the secondary antibodies. DG washout increases the correlation, which is further
enhanced by SP. Pearson’s correlation coefficients are shown for each example.
(E) Tukey box plots showing the first and third quartiles of the distribution of Pearson’s coefficients across multiple cells (n as above). Middle bar shows the
median, outside bars show 10th and 90th percentiles, and + shows the mean. Scale bars represent 5 mm.
(F) Percentage recycling increased during washout, following activation of TGs with fentanyl (n = 37 surf ctrl, 33 intern, 29 rec, and 38 rec + SP).
(G) Tukey box plots showing Pearson’s coefficients from cells in (F).
(H) Percentage recycling increased during washout, following activation of TGs with morphine (n = 37 surf ctrl, 34 intern, 37 rec, and 30 rec + SP).
(I) Tukey box plots showing Pearson’s coefficients from cells in (H).
All error bars are ±SEM.RESULTS
SP Signaling through NK1R Increases Post-endocytic
Recycling of MOR
To test if NK1R signaling cross-regulates MOR recycling, we
chose trigeminal ganglia (TG) neurons as model cells. TG neu-1926 Cell Reports 10, 1925–1936, March 24, 2015 ª2015 The Authorrons are highly relevant for neuralgia, a common and severe
pain disorder, and they endogenously express MOR and NK1R
(Aicher et al., 2000). To measure MOR recycling, we used
an assay to quantitate recycled FLAG-tagged MORs (Fig-
ure 1A). These tagged receptors were fully competent for
signaling and trafficking, as reported previously (Arttamangkuls
Figure 2. SP Signaling through NK1R Regulates Individual MOR Recycling Events
(A) Cells expressing SpH-MOR imagedwith TIRFmicroscopy 5min after DG addition. Frames are 100ms apart. An individual exocytic event is indicated by yellow
arrow. Scale bar represents 5 mm.
(B) Lifetime of an SpH-MORexocytic event. Insertion events begin as a localized, intense burst of fluorescence that diffuseswithin a second. Heatmap of intensity
is shown below as a surface plot.
(C) Maximum intensity traces of an SpH-MOR vesicle exocytic event (top, arrows), showing characteristic rapid spikes and an endocytic cluster (bottom), which
persists for much longer with a characteristic exponential decrease at the end.
(D) Experimental workflow to quantify acute regulation of recycling.
(E) Kymographs of SpH-MOR fusion events from the same region in the same cell, expressing both SpH-MOR and an HA-tagged NK1R, following sequential DG
and SP addition. Arrowheads show exocytic events, which increase after SP. Scale bar represents 2 s.
(F) Number of SpH-MOR exocytic events per minute after SP addition normalized to before (i.e., with just DG) in cells expressing NK1R and in adjacent cells not
expressing NK1R. Error bars are SEM (n = 20). See also Figure S1 and Movies S1, S2, and S3.
All error bars are ±SEM.et al., 2008; Just et al., 2013; Keith et al., 1996; Soohoo and Pu-
thenveedu, 2013). TG neurons expressing FLAG-MOR were
labeled with fluorescent Alexa 488-conjugated anti-FLAG anti-
bodies to detect the existing pool of MOR on the cell surface
(Figure 1B, top left). MOR activation by the specific agonist
[D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, noted as DG)
induced robust MOR internalization, detected by the appear-
ance of intracellular MOR fluorescence (Figure 1B, top right).
DG was then washed out to allow MOR recycling. Next the cells
were labeled by Alexa 568-conjugated secondary antibodies,
which only label surface anti-FLAG-labeled MOR. MOR recy-
cling was quantitated as the ratio of the secondary (surface) to
primary (total) antibody fluorescence values. This ratiometric
assay allowed us to differentiate recycling from the insertion of
newly synthesized MOR. Activation of endogenous NK1Rs by
SP during the agonist washout increased the ratio of surface to
total fluorescence, indicating increased MOR recycling (Figures
1B [bottom] and 1C [right]; Hunt andMantyh, 2001; Nichols et al.,
1999; De Felipe et al., 1998).
We measured the pixel-based colocalization of the surface to
total MOR by calculating the Pearson’s correlation between the
two fluorophores. Before DG, a strong correlation was observed,
as seen in the cytofluorogram (e.g., cell in Figures 1D and 1E). Af-
ter DG, colocalization decreased and two separate populations
emerged, consistent with MOR endocytosis and decreased la-Cellbeling with the secondary antibody on the surface (Figures 1D
and 1E). Colocalization increased when SP was added to the
washout (Figure 1E), suggesting an increase in surface MOR.
We next asked if SP was capable of regulating MOR recycling
when MORs were stimulated with two clinically relevant opioids,
fentanyl and morphine. SP increased MOR recycling after
endocytosis induced by fentanyl (Figures 1F and 1G), but not
morphine (Figures 1H and 1I).
To directly visualize and quantify MOR recycling at the level
of individual recycling events (Yudowski et al., 2006), we
imaged MOR N-terminally tagged with a pH-sensitive GFP,
SpH-MOR (Miesenbo¨ck et al., 1998). When expressed in
HEK293 cells, MOR fluorescence was quenched in acidic en-
dosomal compartments and dequenched upon recycling (Yu-
dowski et al., 2009). Rapid imaging (10 Hz) using total internal
reflection fluorescence (TIRF) microscopy (Puthenveedu et al.,
2010; Yu et al., 2010) after MOR endocytosis revealed individ-
ual exocytic events as transient bursts of fluorescence at the
cell surface (Figure 2A; Movie S1). The fluorescence burst
showed a localized peak of maximum intensity that diffused
across a larger area as vesicles fused and receptors diffused
across the cell surface (Figures 2B [heat map at bottom] and
2C; Movie S2), consistent with our previous data that these
are individual recycling events (Puthenveedu et al., 2010; Yu-
dowski et al., 2009).Reports 10, 1925–1936, March 24, 2015 ª2015 The Authors 1927
Figure 3. PKC Activation Is Required and Sufficient for SP-Induced
Increase in MOR Recycling
(A) Percentage change in number of MOR recycling events, comparing SP to
SP + chel. Chel blocked the SP-mediated increase. DG and either SP or SP +
chel were added sequentially, and a paired comparison wasmade in the same
cell (n = 12).
(B) PMA was sufficient to increase MOR recycling (n = 47 cells).
(C) Assay to detect resensitization of cells to MOR signaling using lumines-
cence-based real-time detection of cAMP levels. The addition of DG reduces
cAMP levels (left). Following DG washout (+ chel or PMA) to allow recycling,
cells were rechallenged with DG. Chel (green) reduced recycling of functional
MOR, while PMA (blue) enhanced it compared to control cells (red). The initial
DG challenge was identical across all experiments. Error bars are SEM across
nine experiments. See also Figure S2.
All error bars are ±SEM.We calculated the percentage change in the number of recy-
cling events after SP by normalizing to the initial rate before SP
(Figure 2D). In cells expressing HA-NK1R, the percentage of
MOR recycling events per minute increased after SP (Figures
2E and 2F; Movie S3), consistent with the increase we saw
with endogenous NK1R (Figures 1C and 1E). In adjacent cells
not expressing HA-NK1R, SP did not increase SpH-MOR recy-
cling (Figure 2F). As HEK293 cells do not express noticeable
levels of endogenous NK1R, this indicates that NK1R signaling1928 Cell Reports 10, 1925–1936, March 24, 2015 ª2015 The Authoris sufficient to increase MOR recycling. MOR recycling was not
reduced by cycloheximide treatment, confirming that these
were post-endocytic recycling events and not the insertion of
newly synthesized protein (Figure S1A). Additionally, very few
MOR recycling events were seen without DG stimulation, and
SP did not change this (Figure S1B). Together, our results
show that SP signaling increases MOR recycling through activa-
tion of the NK1R.
Protein Kinase CSignaling Is Required and Sufficient for
SP-Induced Increase in MOR Recycling and
Resensitization
We next addressed the intracellular NK1R signaling cascade
that mediated the regulation of MOR recycling. NK1R couples
to Gq/11, which activates protein kinase C (PKC) (Macdonald
et al., 1996). The PKC inhibitor chelerythrine (chel) abolished
the SP-induced increase in MOR recycling in NK1R-expressing
cells (Figure 3A), indicating that PKC was required for SP-
and NK1R-mediated regulation of MOR recycling. Additionally,
PKC activation by Phorbol 12-myristate 13-acetate (PMA) in-
creased SpH-MOR recycling in the absence of NK1R and SP
(Figure 3B), indicating that PKC was sufficient for increasing
MOR recycling. The addition of chel or PMA alone had no effect
on SpH-MOR exocytic events (Figures S2A and S2B).
To investigate the functional consequences of PKC-mediated
regulation of MOR recycling, we first measured DG-mediated in-
hibition of cyclic AMP (cAMP) levels as a readout of the number
of functional surface MOR (Talbot et al., 2005). HEK293 cells ex-
pressing MOR were stimulated with DG for 15 min to induce
MOR endocytosis and cellular desensitization. DG was washed
out to allowMOR recycling, and cAMP inhibition in response to a
rechallenge with DGwasmeasured as an index of cellular resen-
sitization. The addition of chel during the washout decreased
cAMP inhibition after the rechallenge (Figure 3C, green line)
compared to the control (Figure 3C, red line). In contrast, PMA
increased cAMP inhibition in response to the DG rechallenge
(Figure 3C, blue line). Chel and PMA alone, with no prior DG stim-
ulation, had no effect on DG-induced inhibition of cAMP produc-
tion (Figure S2C).
We next tested if PKC inhibition abolishes the SP-induced in-
crease in MOR recycling in TG neurons, using the ratiometric re-
cycling assay (Figure 1). The addition of chel during the washout
abolished the SP-mediated increase in MOR recycling (Figures
4A and 4B). Pixel-based colocalization was lower when PKC
was inhibited in the washout, even in the presence of SP (Fig-
ure 4C). Adding PMA without SP during the washout increased
MOR recycling (Figures 4D and 4F). Together, this suggests
that PKC is both required and sufficient for the regulation of
MOR recycling and cellular sensitivity to opioid signaling.
SP- and PKC-Mediated Regulation of MOR Recycling
Requires MOR Phosphorylation at Ser 363 and Thr 370
Considering that PKC was required and sufficient for heterolo-
gous regulation ofMOR recycling through SP, we sought to iden-
tify the target of PKC. The MOR itself presented an interesting
candidate. PKC can phosphorylate three sites on the C-terminal
tail of MOR: serine 363, threonine 370, and serine 375 (Figure 5A;
Doll et al., 2011; Feng et al., 2011). To test whether MORs
Figure 4. PKC Activation Is Required and Sufficient for SP-Induced Increase in MOR Recycling in TG Neurons
(A) Ratiometric recycling assay in TG neurons comparing MOR recycling in the presence of SP alone versus SP with chel. Scale bar represents 10 mm.
(B) Quantitation across multiple cells as in Figure 1C (mean ± SEM; n = 77 surf ctrl, 78 intern, 72 rec + SP, 47 rec + SP + chel).
(C) Tukey box plots of Pearson’s coefficients from cells in (B).
(D and E) Ratiometric recycling assay in TG neurons testing the effect of PKC activation by PMA in the absence of SP (n = 77 surf ctrl, 78 intern, 69 rec, 47 rec +
PMA).
(F) Tukey box plots of Pearson’s coefficients from cells in (E).
All error bars are ±SEM.phosphorylation was required, wemutated each of these sites to
alanine to block phosphorylation (Feng et al., 2011) and quanti-
fied SP-mediated regulation of MOR recycling. SP did not in-
crease the percentage of recycling events per unit time when
either S363 or T370 was mutated (Figures 5B and 5C). In
contrast, the recycling of S375A increased to a level comparable
towild-type in response to SP (Figures 5B and 5C). This indicates
that S363 and T370 are required for SP-mediated regulation, but
S375 is not (Figures 5B and 5C). Additionally, PMA increased
SpH-MOR exocytic events for S375A, but not S363A or T370A,
comparable to wild-type MOR (Figure 5D). In TG neurons, SP
failed to increase S363A or T370A recycling (Figures 5E–5G for
S363A and Figures 5H–5J for T370A), indicating that both
S363 and T370 are required for PKC to regulate MOR recycling.
PKC Enhances Recycling and Resensitization of
Endogenous MORs in TG Neurons
We next asked if endogenous MOR trafficking was regulated by
PKC. To test this, we utilized a rabbit monoclonal anti-MOR anti-
body (UMB-3) to detect the subcellular localization of endoge-Cellnous MORs (Lupp et al., 2011). UMB-3 staining showed strong
staining at the periphery of TG neurons (Figure 6A), further indi-
cated by the surface plot of intensity (Figure 6A, insets). To quan-
titate intracellular versusmembraneMOR levels, UMB-3 fluores-
cence wasmeasured across concentric circles increasing in size
from the center to the periphery of the cell (Figure 6B). At steady
state, the majority of UMB-3 maximum fluorescence intensity
was detected in larger circles, consistent with more MOR local-
ized to the surface (Figure 6B). After DGaddition, UMB-3 staining
was visible in punctate structures, and fluorescence intensity
was uniform across the cell (Figures 6A and 6B), suggesting
redistribution of MOR to endosomes. DG washout restored
UMB-3 staining at the periphery of TG neurons (Figures 6A and
6B), consistent with MOR recycling. PKC inhibition during the
washout inhibited MOR recycling, as evidenced by the retention
of UMB-3 fluorescence in punctate structures and uniform fluo-
rescence in smaller circles (Figures 6A and 6B). Conversely, PKC
activation during the washout caused strong UMB-3 staining at
the cell periphery (Figures 6A and 6B), suggesting that PKC in-
creases endogenous MOR recycling.Reports 10, 1925–1936, March 24, 2015 ª2015 The Authors 1929
Figure 5. PKC Requires S363 and T370 to Regulate MOR Recycling
(A) Schematic of PKC phosphorylation sites on C-terminal tail of MOR (S363, T370, and S375).
(B) Kymographs of SpH-MOR single exocytic events for MOR S363A, T370A, and S375A after SP.
(C) Quantitation of percentage recycling across cells (n = 20, 14, 18, and 22) in HA-NK1R-expressing cells with MOR mutants S363A and T370A, and S375,
compared to wild-type. Dashed line shows number of events in same cells prior to SP normalized to 100%.
(D) Percentage recycling with PMA-treated cells expressing MOR mutants S363A, T370A, and S375A (n = 52, 29, 18, and 17).
(E) Ratiometric recycling assay in TG neurons for S363A with and without SP. Scale bar represents 10 mm.
(F) Ratio quantitation across multiple cells (mean ± SEM; n = 35 surf ctrl, 38 intern, 33 rec, 41 rec + SP) between the washout without and with SP for S363A.
(G) Tukey box plots of Pearson’s coefficients from S363A cells in (F) show no increase in correlation with SP.
(H) Ratiometric recycling assay in TG neurons for T370A with and without SP.
(I) Ratio quantitation (n = 47, 27, 29, and 27) without and with SP for T370A.
(J) Tukey box plots of Pearson’s coefficients from T370A cells in (I) show no increase in correlation with SP. Scale bars represent 5 mm.
All error bars are ±SEM.To further test PKC’s regulation of endogenousMOR recycling
in TG neurons, we used a fluorescent ligand, Alexa 594-conju-
gated dermorphin (derm594), previously described to bind
MORs (Arttamangkul et al., 2000). To induce recycling, we
treated TG neurons with DG, followed by a washout as in the re-1930 Cell Reports 10, 1925–1936, March 24, 2015 ª2015 The Authorsensitization experiment in Figure 3C. At the end, the cells were
labeled with ice-cold derm594 to detect surface MOR. When
compared to the control, DG significantly decreased derm594
fluorescence, consistent with MOR endocytosis. After wash-
out, derm594 fluorescence was higher than the DG control,s
Figure 6. PKC Increases Recycling of Endogenous MOR and Opioid Resensitization in TG Neurons
(A) Example images of anti-MOR (UMB-3) in TG neurons. UMB-3 staining was primarily localized to the periphery in untreated cells (orange arrowheads). DG
addition for 20 min induced a redistribution of UMB-3 staining to intracellular punctate structures (blue arrows). DG washout (20 min) induced greater UMB-3
staining at the periphery, similar to the untreated control. Addition of chel during the washout shifted UMB-3 staining to punctate structures, while PMA addition
enhanced staining at the cell periphery. Insets show surface plots as heat maps.
(B) Schematic of radial profile method used to analyze fluorescence intensity of UMB-3 staining from the center to the periphery of cells. Intensity traces from
multiple cells (mean ± SEM; n > 8 in each condition) show increased UMB-3 fluorescence in circles of larger radii, consistent with increasedMOR on the surface.
Higher fluorescence in larger radii denotes surface, while uniform fluorescence denotes internal pools.
(C) Graph of average mean intensity of derm-A594 signal labeling endogenous MOR in TG neurons across three trials (mean ± SEM) Derm-A594 fluorescence
was significantly greater in non-treated TGs (no treatment) than HEK cells (neg ctrl), indicating specific binding. DG induced internalization, as shown by lower
fluorescence (black bars). Washout increased fluorescence (red). Chel blocked this increase in fluorescence (green) and PMA enhanced it (blue).
(D) Graphs of mean fluorescence values of DiBAC4(5) in TG neurons, at 15 min after DG addition and DG rechallenge after the washout alone (left), with chel
(center), and with PMA (right). Corresponding p values (mean ± SEM; n > 5 in each condition) are shown for each.
All error bars are ±SEM.as expected after MOR recycling. PKC inhibition decreased
derm594 fluorescence, and PKC activation increased it, sug-
gesting that PKC increases recycling of endogenous MOR
(Figure 6C). HEK293 cells not expressing MOR did not show
fluorescence, confirming specificity of derm594 binding (Fig-
ure 6C). Together, these results suggest that PKC is required
and sufficient to regulate recycling of endogenous MORs.
SP and PKC Regulate the Opioid Resensitization in
Neurons and Opioid Analgesia in Mice
We next asked if PKC regulated the resensitization of opioid ac-
tivity in physiologically relevant sensory neurons. TG neuronsCellwere incubated with the sulfonyl voltage-sensitive anionic dye
DiBAC4(5) (George et al., 1988), which increases fluorescence
on depolarization and decreases fluorescence on hyperpolar-
ization. DG decreased the fluorescence of KCl-activated TG
neurons, consistent with opioid-induced hyperpolarization (Fig-
ure 6D). To measure MOR recycling and resensitization, we
used the agonist-washout paradigm above (Figures 6A–6C).
After the initial DG challenge, DG was washed out for 20 min
to allow recycling and resensitization. A rechallenge with DG
decreased the KCl-induced voltage change similarly to the initial
challenge, indicating that neurons were resensitized to opioid
signaling (Figure 6D, left). However, when PKC was inhibitedReports 10, 1925–1936, March 24, 2015 ª2015 The Authors 1931
Figure 7. SP Reduces Acute Tolerance to
Fentanyl, but Not Morphine
(A) Timecourseof fentanyl-inducedantinociceptive
responses. An increase in tail-withdrawal latencies
denotes antinociception. The response after the
second fentanyl injection is higher in SP-injected
mice. Results are mean ± SEM (n = 9).
(B) Graph of areas under the curve for initial
response and rechallenge for each condition.
(C) Time course of morphine-induced anti-
nociceptive responses. Unlike fentanyl, the sec-
ond morphine injection resulted in a lower res-
ponse for both the vehicle control and SP-injected
mice (mean ± SEM; n = 10 and 11).
(D) Graph of areas under the curve as in (B). See
also Figure S3.
All error bars are ±SEM.during the DG washout, the DG rechallenge did not decrease
fluorescence, consistent with fewer receptors recycling back
to the surface (Figure 6D, middle). Further, PKC activation during
the DG washout enhanced the effect of the DG rechallenge
(Figure 6D, right). This suggests that PKC regulates opioid resen-
sitization in sensory neurons, consistent with our model that
SP-mediated PKC activation positively regulates MOR recycling
and resensitization.
To test if SP regulated the resensitization of MOR-mediated
analgesia in mice, we measured the development of acute
tolerance to the antinociceptive effects of fentanyl, a short-
acting MOR agonist, using a warm-water tail-withdrawal
assay (Melief et al., 2010; Pradhan et al., 2010; Figure S3A).
After baseline measurements, animals were injected with fen-
tanyl, and tail-withdrawal latencies were measured every
30 min. A significant but sub-maximal increase in tail-with-
drawal latencies, persisting for approximately 120 min, was
observed with fentanyl (Figure 7A). Either saline (vehicle con-
trol) or SP was injected intrathecally 120 min after the first
fentanyl challenge. In control mice, a fentanyl rechallenge,
given 30 min later, attenuated (40% of initial) the antinoci-
ceptive response, indicating acute tolerance to fentanyl (Fig-
ure 7A). In contrast, SP-injected mice showed an antinocicep-
tive response to the rechallenge that was comparable to the
initial response (Figures 7A and S3B). Calculation of the areas
under the curve showed that saline-injected mice showed a
significantly reduced response to the fentanyl rechallenge
compared to the initial response, while SP-injected mice
showed comparable responses to both fentanyl injections
(Figure 7B). Because morphine-activated MORs were not1932 Cell Reports 10, 1925–1936, March 24, 2015 ª2015 The Authorssubject to SP-regulated recycling, we
next tested if SP could sensitize
morphine-induced analgesia in mice.
Consistent with our cellular data, a
morphine rechallenge following SP in-
jection did not increase tail-withdrawal
latency in contrast to fentanyl (Figures
7C and 7D and S3C). Taken together,
our results indicate that SP signaling
through PKC inhibits acute toleranceto fentanyl, but not morphine, by increasing MOR recycling
in peripheral neurons.
DISCUSSION
We show that SP signaling, through endogenous NK1R, en-
hances MOR recycling following DG- and fentanyl-, but not
morphine-induced endocytosis (Figures 1 and 2). PKC activity
downstream of NK1R is required and sufficient for this crosstalk
(Figures 3 and 4). We identify two PKC sites on the C-terminal tail
of MOR as the targets for this NK1R-mediated regulation (Fig-
ure 5), and show a functional effect of PKC regulation in the recy-
cling of exogenous and endogenous MOR in sensory neurons
(Figure 6). Further, we show that SP increases opioid antinoci-
ception in mice by attenuating acute tolerance to fentanyl, but
not morphine.
Studies over the last decades have suggested a complex and
paradoxical interaction between the neurokinin and opioid path-
ways. SP, a pain-associated neurotransmitter, can induce anti-
nociceptive effects (Mohrland and Gebhart, 1979). Further,
NK1R antagonists can modify opioid reward, withdrawal, and
reinforcement, and NK1R is required for morphine reward but
not morphine analgesia (Gadd et al., 2003; Murtra et al., 2000).
Our data, that SP regulates MOR recycling and acute tolerance
to fentanyl, but not morphine (Figure 7), are consistent with this,
but suggest a complex agonist-selective crosstalk between
these pathways. At a cellular level, co-activation of NK1R and
MOR in CNS neurons has been reported to inhibit MOR endocy-
tosis, partly because NK1R non-specifically sequesters beta-ar-
restin, the common adaptor required for GPCR endocytosis
(Pierce et al., 2002; Yu et al., 2009), and partly because the re-
ceptors might heterodimerize (Pfeiffer et al., 2003). We directly
measured individual recycling events, which allowed us to test
acute regulation of MOR recycling induced by NK1R signaling
in the same cell (Figure 2), free of the potentially confounding ef-
fect of NK1R on MOR endocytosis. Further, in our ratiometric
assay, NK1Rs were activated after MOR was endocytosed,
and the presence of a MOR antagonist prevented subsequent
endocytosis. Therefore, we believe endocytosis has a negligible
effect on the crosstalk we observed here. Further, blocking new
MOR synthesis (Figure S1) had no effect on the surface delivery
of MOR in our assays, and inhibition or activation of PKC without
DG did not cause any change in MOR surface levels or induce
surface insertion (Figure S2). Therefore, the increase in surface
MOR we observed was primarily a result of increased recycling
(Figures 1 and 2).
The precise role of PKC in modulating opioid physiology and
MOR trafficking is unresolved (Raehal et al., 2011; Williams
et al., 2013), but it provides a potential control point for physio-
logical regulation of opioid signaling. PKC has been implicated
in controlling opiate resensitization, tolerance, and dependence,
and PKC activation during prolonged MOR agonist exposure in-
creases desensitization, possibly by endocytosis (Dang andWil-
liams, 2004; Inoue and Ueda, 2000; Bailey et al., 2004; Kramer
and Simon, 1999). Given that MOR itself can activate PKC,
such homologous PKC activation during chronic MOR activation
might regulate desensitization and endocytosis, whereas injury
and inflammatory pain might alter the balance of MOR trafficking
and resensitization through heterologous SP regulation, consis-
tent with data that peripheral MORs are less active prior to injury
or pain (Berg et al., 2007; Chen and Marvizo´n, 2009).
Such distinct cell-type or environment-dependent conse-
quences could be brought about by differential MOR phosphor-
ylation. Because we added SP after the major fraction of MOR
already was internalized, we believe that the endosomal pool
of MOR can be phosphorylated by PKC. Of the two MOR PKC
targets required for SP-mediated increase in MOR recycling,
S363 was constitutively phosphorylated, while T370 phosphory-
lation was regulated. Interestingly, T370 was phosphorylated by
DG, but not morphine (Doll et al., 2011). However, it was robustly
phosphorylated by heterologous SP and PKC activity (Illing et al.,
2014; Mann et al., 2015), so it is unlikely to be the primary expla-
nation for the differences we saw between DG and morphine.
S375 might be phosphorylated primarily by GPCR kinases
(GRK) rather than PKC (Doll et al., 2012), consistent with our
result that S375 was not required for NK1R’s regulation of
MOR recycling via PKC. Additionally, T370 might be phosphory-
lated by GRK 2/3 following MOR activation with a hierarchical
dependence on S375 phosphorylation (Just et al., 2013), and in-
hibition of GRK2 alleviates opiate tolerance (Dang et al., 2011).
Further, SP induced PKC-dependent phosphorylation of MOR
at T370 without dependence on S375 phosphorylation (Illing
et al., 2014). It is possible that T370 is differentially phosphory-
lated by PKCs and GRKs by homologous versus heterologous
regulation to control physiological consequences in different
cell types. Homologous GRK-mediated phosphorylation of
MOR following the addition of opioid agonists might promote
opioid tolerance in the CNS, while PKC phosphorylation atCellT370 following NK1R activation induces resensitization of
MORs in the context of inflammatory pain in the peripheral ner-
vous system (PNS).
T370 and S363 are adjacent to a bi-leucine sequence that is
required and sufficient forMOR recycling (Tanowitz and von Zas-
trow, 2003). This raises the possibility that combinatorial MOR
phosphorylation by homologous and heterologous signaling
pathways might rapidly reprogram receptor recycling and
cellular resensitization by changing the biochemical interactions
of MOR. Reprogramming in response to homologous regulation
has been suggested for B2AR recycling, which switches be-
tween a sequence-dependent and bulk recycling pathway
based on PKA phosphorylation (Puthenveedu et al., 2010; Vis-
tein and Puthenveedu, 2013). MOR recycling in striatal neurons
has been reported to be inhibited by forskolin, though PKA
was not directly tested (Roman-Vendrell et al., 2012). Striatal
neurons do not co-express NK1R and MOR, and it is possible
that different neuronal subtypes exhibit distinct mechanisms of
regulation, depending on the expression profiles of signaling re-
ceptors and kinases. Rapid reprogramming by receptor phos-
phorylation could therefore be a general mechanism to switch
receptors between different recycling pathways, depending on
the physiological circumstance. For MOR, such reprogramming,
causing sensitization of nociceptors to opioid signaling, could in
part explain the paradoxical analgesic effects of capsaicin and
SP (Komatsu et al., 2009; Mohrland and Gebhart, 1979). We
show that peripheral administration of SP is capable of in-
creasing MOR-mediated analgesia in mice. This is consistent
with data that peripheral endogenous opioids are released
following tissue damage and painful stimuli, and that this is
accompanied by an increase in opioid receptors to nerve termi-
nals (Stein and Lang, 2009). As the opioid system serves as a
physiological check for the maladaptive consequences of
pain, our results provide a proof of principle for how signaling
crosstalk between these systems at the level of receptor traf-
ficking could represent a general homeostatic mechanism of
signaling crosstalk.
EXPERIMENTAL PROCEDURES
Plasmid DNA and Constructs
FLAG-MOR and SpH-MOR have been described previously (Keith et al., 1996;
Soohoo and Puthenveedu, 2013). HA-tagged rat NK1R was provided by
Dr. Mark von Zastrow. Point mutants were generated using site-directed
mutagenesis with QuikChange (Agilent Technologies). All constructs were
confirmed by DNA sequencing.
Cell Cultures and Transfections
TG neurons were obtained as previously described (Malin et al., 2007), and
transfected using Lipofectamine 2000 (Invitrogen) 2 days after plating. Cells
were maintained for 2 days in culture before imaging. HEK293 cells were
obtained from ATCC and maintained in DMEM (Fisher Scientific) + 10%
fetal bovine serum (FBS). Cells were transfected with Effectene (QIAGEN).
Stable cell lines were generated with Geneticin (Invitrogen) selection. Cells
were passed to 25 mm coverglass 1 day after transfection and imaged the
following day.
Immunofluorescence Ratiometric Recycling Assay and
Quantification
TGs expressing FLAG-MOR were labeled with Alexa 488-conjugated M1 anti-
FLAG to label surface receptors for 10 min, followed by incubation with 10 mMReports 10, 1925–1936, March 24, 2015 ª2015 The Authors 1933
DG (Sigma-Aldrich) for 20min to promote receptor internalization. Agonist me-
dia were washed out and replaced with media containing 10 mM naltrexone
(Sigma), a MOR antagonist, to prevent additional activation and internalization
of MOR for 20 min. Recycled surface M1-anti-FLAG-labeled receptors were
then labeled with secondary goat anti-mouse conjugated to Alexa 568 for
10 min at 4C. All other incubations were performed at 37C. Cells were
then fixed with 4% paraformaldehyde (PFA) for 20 min, and blocked with
0.1 M glycine in complete PBS for 10 min.
A surface control was performed, where cells were labeled for 10 min with
Alexa 488-M1 anti-FLAG, immediately followed by Alexa 568-secondary
goat anti-mouse to quantify the steady-state amount of surface receptors.
An endocytosis control was performed, where cells were labeled with the sec-
ondary antibody and fixed, to quantify the amount of receptors internalized in
the presence of DG. The percentage recycling was calculated from the ratio of
intensities of the secondary antibody to the primary anti-FLAG and by dividing
experimental conditions by the surface control minus the endocytosis control
(expt condition  endo ctrl)/(surf ctrl  endo ctrl)%. Just Another Colocaliza-
tion Plugin (JACoP) for ImageJ was used to generate a cytofluorogram and
Pearson’s correlation coefficient of intensities between primary and secondary
antibody fluorescence. Statistical analyses and graphing were done using Mi-
crosoft Excel and GraphPad Prism. p values are from Mann-Whitney tests.
Individual Exocytic Event Recycling Assay
HEK293 cells stably expressing SpH-MOR were incubated in DG for 5 min,
and a 1-min movie was acquired at 10 Hz using TIRF microscopy, followed
by subsequent incubation with the second drug and a 1-min movie, at 37C.
For SP experiments, cells were transiently transfected with HA-NK1R.
Cells were incubated in anti-HA (Sigma-Aldrich), followed by Alexa 568-goat
anti-mouse, both for 10 min. Cells were incubated for 5 min with DG, and a
1-min movie was acquired. SP was added for 5 min, followed by a 1-min
movie. Individual insertion events were manually counted using a double-blind
process. A paired comparison was made within the same cell, normalizing to
the agonist-only treatment. Significance was determined through Student’s
paired t test.
Live Cell and Fluorescence Imaging
Cells were imaged using a Nikon TE-2000E inverted microscope with a 603
1.49 NA TIRF objective, Andor Revolution XD spinning disk confocal system,
and 488 and 568 nm solid-state lasers. Cells were imaged in Opti-MEM or Lei-
bowitz’s L15 medium (Gibco), 5% FBS, at 37C. Time lapses were acquired
using an Andor iXon+ EM-CCD camera using Andor IQ. Original 16-bit tif files
acquired directly from the camera were used for image analysis.
Fluorescent Ligand Binding
TG neurons were plated on a clear-bottom black 96-well plate for 2 days.
Cells were stimulated with DG for 15 min to induce internalization, followed
by a 15-min DG washout with naltrexone to induce MOR recycling, at 37C.
Two parallel controls, no DG or naltrexone treatment and a DG-only treatment,
were performed. Cells were washed and labeled with 100 nM derm594 (in cold
PBS, Ca/Mg) at room temperature, then washed out two times. Fluorescence
was recorded on a Tecan Safire II Plate Reader at (at 25C). Derm594 was
generously donated by Dr. John Williams (Vollum Institute).
UMB-3 Immunofluorescence Staining
TG neurons, plated on coverglass, were treated either with DG (endo ctrl), no
drug (surf ctrl), or incubated with DG for 20 min, followed by agonist washout
with antagonist and vehicle, chel, or PMA for 20min (recycling). Cells were then
fixed in 4% PFA for 25 min, blocked, and permeabilized in PBS + Ca/Mg, FBS,
and 0.01%Triton for 45min. Cells were incubated with UMB-3 in PBS+Ca/Mg
at 4C overnight, and labeled with Alexa 488-goat anti-rabbit secondary anti-
body, mounted, and imaged.
cAMP Measurement
Assays were performed on HEK293 cells stably expressing MOR and cAMP-
Glo Sensor 20F (Promega), at 35C with IBMX. Luminescence was continu-
ously recorded using a Tecan Infinite M1000 Plate Reader. After 5 min of
baseline, DG was added for 10 min to record the initial response and allow1934 Cell Reports 10, 1925–1936, March 24, 2015 ª2015 The Authorendocytosis; media were washed out and replaced with media with naltrexone
and either PMA, chel, or vehicle for 20min for recycling. A rechallenge with DG
was used to measure resensitization of recycled MORs.
Voltage-Sensitive Dye Measurement
For control KCl and DG experiments, TG neurons were labeled with DiBAC4(5)
and imaged every 30 s. Then 80mMKCl was added to depolarize TGs, and DG
was added 5 min after KCl to activate endogenous MORs. Cells were incu-
bated with 10 mM DG for 15 min. The agonist was washed out and replaced
with media and 10 mM naltrexone and PMA or chel, and compared to
naltrexone-only washout. The antagonist was washed out, for 20 min (chel)
or 10 min (PMA), and cells were labeled with DiBAC4(5). Cells were rechal-
lenged 5 m after KCl with 10 mM DG and imaged. Mean fluorescence was
analyzed using ImageJ, and statistical analyses and graphing were performed
in GraphPad Prism.
Tail Immersion Assay
Subjects were male C57BL6/J mice between 9 and 12 weeks old. Animals
were group housed in a 14 hr/10 hr light/dark cycle, and food and water
were available ad libitum. All experiments were in accordance with the Asso-
ciation for Assessment and Accreditation of Laboratory Animal Care Interna-
tional (AALAC) guidelines and were approved by the Animal Care Committee
at the University of Illinois, Chicago. Thermal nociception was determined us-
ing the warm-water tail-withdrawal assay. Animals were initially habituated to
the test apparatus for 2 days before testing. On the test day, mice were lightly
restrained in a conical restraint bag, and their tails were immersed (5 cm from
the tip) into a 52.5C water bath. Tail-withdrawal latencies were determined,
and a cutoff of 12 s was established. After three basal measurements, mice
were injected with fentanyl (0.1 mg/kg, subcutaneously [SC]) or morphine
(5 mg/kg, SC), and tested every 30 min for 4.5 to 6 hr (Melief et al., 2010). At
120 min (fentanyl) or 210 min (morphine), mice were injected intrathecally
with 5 ml SP (10 ng) or 0.9% saline. Intrathecal injections were performed
with a 30-gauge, 1/2-inch needle at the L4–5 lumbar interspace on lightly anes-
thetizedmice. Tail twitch was used to confirm needle placement, and anymice
that exhibited motor impairment following intrathecal injection were excluded.
Mice were injected 30 min later with a second injection of fentanyl (0.1 mg/kg,
SC) or morphine (5 mg/kg, SC), and tested every 30 min until tail-withdrawal
latencies returned back to baseline responses.
SUPPLEMENTAL INFORMATION
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